Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

COVID-19 symptom duration predicts immunoglobulin G seropositivity

L. Stepanek, M. Nakladalova, L. Stepanek, M. Janosikova, A. Borikova, H. Vildova

. 2021 ; 122 (12) : 861-865.

Jazyk angličtina Země Slovensko

Perzistentní odkaz   https://www.medvik.cz/link/bmc22022117

OBJECTIVES: The study focused on the relationship between routine clinical characteristics and anti-SARS-CoV-2 specific antibodies in a pilot sample of healthcare workers (HCWs) having suffered COVID-19. The aim was to investigate the existence of readily available predictors of antibodies against COVID-19. METHODS: As part of the recognition of COVID-19 as an occupational disease in 152 HCWs with the mean age of 43.2 years, personal, anthropometric and anamnestic data related to the disease as well as anti-spike immunoglobulin (Ig) levels were obtained. Through descriptive statistics, correlation and regression analyses, relationships of all variables and Ig levels, especially seropositivity of IgG, were investigated. RESULTS: The mean interval between the symptom onset and the determination of antibodies was 58 days. IgG seropositivity and IgM seropositivity were noted in 82 % and 49 % of HCWs, respectively. Symptom duration was the only statistically significant predictor of IgG seropositivity. With each day of symptom duration, the probability of IgG seropositivity increased from 1.078 to 1.092 times (p < 0.05). If symptoms lasted longer than 17 days, a majority (almost 80 %) of the subjects demonstrated seropositivity in the following months. CONCLUSION: The presence of IgG immunity may be assumed from symptom duration. Such easy recognizing of seropositive patients may be a useful tool, e.g. in vaccination strategies (Tab. 3, Fig. 1, Ref. 28).

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22022117
003      
CZ-PrNML
005      
20221023002318.0
007      
cr|cn|
008      
220919s2021 xo fs 000 0|eng||
009      
AR
024    0_
$a 10.4149/BLL_2021_139 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xo
100    1_
$a Štěpánek, Ladislav $7 xx0224068 $u Department of Occupational Medicine, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
245    10
$a COVID-19 symptom duration predicts immunoglobulin G seropositivity / $c L. Stepanek, M. Nakladalova, L. Stepanek, M. Janosikova, A. Borikova, H. Vildova
504    __
$a Literatura
520    9_
$a OBJECTIVES: The study focused on the relationship between routine clinical characteristics and anti-SARS-CoV-2 specific antibodies in a pilot sample of healthcare workers (HCWs) having suffered COVID-19. The aim was to investigate the existence of readily available predictors of antibodies against COVID-19. METHODS: As part of the recognition of COVID-19 as an occupational disease in 152 HCWs with the mean age of 43.2 years, personal, anthropometric and anamnestic data related to the disease as well as anti-spike immunoglobulin (Ig) levels were obtained. Through descriptive statistics, correlation and regression analyses, relationships of all variables and Ig levels, especially seropositivity of IgG, were investigated. RESULTS: The mean interval between the symptom onset and the determination of antibodies was 58 days. IgG seropositivity and IgM seropositivity were noted in 82 % and 49 % of HCWs, respectively. Symptom duration was the only statistically significant predictor of IgG seropositivity. With each day of symptom duration, the probability of IgG seropositivity increased from 1.078 to 1.092 times (p < 0.05). If symptoms lasted longer than 17 days, a majority (almost 80 %) of the subjects demonstrated seropositivity in the following months. CONCLUSION: The presence of IgG immunity may be assumed from symptom duration. Such easy recognizing of seropositive patients may be a useful tool, e.g. in vaccination strategies (Tab. 3, Fig. 1, Ref. 28).
650    _7
$a dospělí $7 D000328 $2 czmesh
650    _7
$a ženské pohlaví $7 D005260 $2 czmesh
650    _7
$a lidé $7 D006801 $2 czmesh
650    _7
$a mužské pohlaví $7 D008297 $2 czmesh
650    _7
$a lidé středního věku $7 D008875 $2 czmesh
650    17
$a COVID-19 $x imunologie $7 D000086382 $2 czmesh
650    _7
$a nemoci z povolání $x imunologie $7 D009784 $2 czmesh
650    17
$a imunoglobulin G $x imunologie $x krev $7 D007074 $2 czmesh
650    _7
$a zdravotnický personál $x statistika a číselné údaje $7 D006282 $2 czmesh
650    _7
$a průřezové studie $7 D003430 $2 czmesh
650    _7
$a Kaplanův-Meierův odhad $7 D053208 $2 czmesh
650    _7
$a logistické modely $7 D016015 $2 czmesh
650    _7
$a statistika jako téma $7 D013223 $2 czmesh
650    _7
$a regresní analýza $7 D012044 $2 czmesh
651    _7
$a Česká republika $7 D018153 $2 czmesh
653    00
$a séropozitivita
653    00
$a trvání nemoci
700    1_
$a Nakládalová, Marie $7 stk2008428573 $u Department of Occupational Medicine, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Štěpánek, Lubomír $7 xx0245289 $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Janošíková, Magdaléna $7 xx0245281 $u Department of Occupational Medicine, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Boriková, Alena $7 xx0229693 $u Department of Occupational Medicine, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Vildová, Helena $7 xx0106811 $u Department of Occupational Medicine, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
773    0_
$t Bratislavské lekárske listy $x 0006-9248 $g Roč. 122, č. 12 (2021), s. 861-865 $w MED00000845
856    41
$u http://www.elis.sk/download_file.php?product_id=7485&session_id=8hjh2tfuhm3g9gnv52k2jkrea7 $y plný text volně přístupný
910    __
$a ABA008 $b online $c 1067 $y p $z 0
990    __
$a 20220919103837 $b ABA008
991    __
$a 20221023002309 $b ABA008
999    __
$a ok $b bmc $g 1839271 $s 1173387
BAS    __
$a 3 $a 4
BMC    __
$a 2021 $b 122 $c 12 $d 861-865 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845
LZP    __
$c NLK189 $d 20221023 $a NLK 2022-01/kv

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...